SELLAS Life Sciences Group, Inc. (SLS)
8.56
+0.44
(+5.42%)
USD |
NASDAQ |
May 27, 16:00
8.63
+0.07
(+0.82%)
After-Hours: 17:46
SELLAS Life Sciences Group Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Rezolute, Inc. | 12.28M |
| Krystal Biotech, Inc. | -63.58M |
| Spero Therapeutics, Inc. | 0.00 |
| Recursion Pharmaceuticals, Inc. | -0.338M |
| Whitehawk Therapeutics, Inc. | 19.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.846M |
| Cash from Financing (Quarterly) | 44.15M |
| Free Cash Flow | -28.16M |
| Free Cash Flow Per Share (Quarterly) | -0.0513 |
| Free Cash Flow to Equity (Quarterly) | -8.716M |
| Free Cash Flow to Firm (Quarterly) | -8.846M |
| Free Cash Flow Yield | -2.47% |